|
Sign In to gain access to subscriptions and/or personal tools.
|
Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential ( m) in the pancreatic β-cell line NIT-1
Petra Augstein
Institute of Diabetes "Gerhardt Katsch" Karlsburg e.V., Karlsburg, Germany.
Peter Heinke
Institute of Diabetes "Gerhardt Katsch" Karlsburg e.V., Karlsburg, Germany.
Eckhard Salzsieder
Institute of Diabetes "Gerhardt Katsch" Karlsburg e.V., Karlsburg, Germany.
Rita Grimm
Department of Physiology of the Ernst-Moritz-Arndt University of Greifswald, Karlsburg, Germany.
Jürgen Giebel
Department of Anatomy of the Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany.
Christel Salzsieder
Institute of Diabetes "Gerhardt Katsch" Karlsburg e.V., Karlsburg, Germany.
Leonard C Harrison
Autoimmunity and Transplantation Division, the Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential ( m) in the pancreatic β-cell line NIT-1. NIT-1 cells were exposed to the interleukin-1 β/interferon- (IL-1 β/IFN- ) cytokine combination to induce apoptosis in vitro. Low concentrations of cytokines resulted in  m impairment, and increasing concentrations had only a minor additional effect. Treatment with the inducible nitric oxide synthase (iNOS) inhibitor N -nitro-L-arginine methyl ester hydrochloride (L-NAME) prevented cytokine-mediated  m impairment, implying that cytokines affect  m via nitric oxide. The broad-spectrum caspase inhibitor Z-VAD(Ome)-FMK (ZVAD) revealed dichotomic actions. In the presence of ZVAD, cytokine-induced nitrite generation was increased but cell death and  m impairment were reduced.  m impairment was also reduced by inhibitors of caspases 1, 6 and 8. Induction of Fas by IL-1 β/IFN- coupled with activation by Super-FasL augmented cytokine-induced cell death. We observed a clear dominance of cytokine- over FasL-induced effects on  m.
Our findings show that IL-1 β/IFN- cytokines have a strong effect to impair  m and prime β-cells for apoptosis via the intrinsic pathway mediated by iNOS and caspases. Furthermore, at least in NIT-1 cells, the extrinsic FasL/Fas pathway has only a minor additive effect on cytokine-induced  m impairment.
Key Words: β-cell line NIT-1 cytokine-induced apoptosis FasLigand-induced apoptosis mitochondrial transmembrane potential type 1 diabetes
References
- 1. Barnhart BC Alappat EC, Peter EM. The CD95 type I/type II model. Semin Immunol 2003;15:185–93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 2. Kroemer G. Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 2003;304:433–5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 3. Vieira H Kroemer G Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 2003;55:613–16.[Web of Science][Medline]
[Order article via Infotrieve]
- 4. Fadeel B Orrenius S Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 2005;258:479–518.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 5. Riedl SJ Salvesen SG. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007;8:405–13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 6. Ly JD Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003;8:115–28.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 7. Zamzami N Metivier D, Kroemer G. Quantitation of mitochondrial transmembrane potential in cells and in isolated mitochondria. Methods Enzymol 2000;322:208–13.[Web of Science][Medline]
[Order article via Infotrieve]
- 8. Eizirik DL Mandrup-Poulsen T. A choice of death – the signal-transduction of immune-mediated beta cell apoptosis. Diabetologia 2001;44:2115–33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 9. Eizirik DL Kutlu B, Rasschaert J, Darville M, Cardozo KA. Use of microarray analysis to unveil transcription factor and gene networks contributing to Beta cell dysfunction and apoptosis. Ann N Y Acad Sci 2003;1005:55–74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 10. Mandrup-Poulsen T. Beta cell death and protection. Ann N Y Acad Sci 2003;1005:32–42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 11. Wollheim CB. Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 2000;43:265–77.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 12. Augstein P Wachlin G, Berg S et al. Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells. J Mol Endocrinol 2003;30:163–71.[Abstract]
- 13. Garrido C Kroemer G Life's smile, death's grin: vital functions of apoptosis-executing proteins. Curr Opin Cell Biol 2004;16:639–46.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 14. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 2000;141:2003–10.[Abstract/Free Full Text]
- 15. Kwon KB Kim EK, Lim JG et al. Protective effect of Coptidis Rhizoma on S-nitroso-N-acetylpenicillamine (SNAP)-induced apoptosis and necrosis in pancreatic RINm5F cells. Life Sci 2005;76:917–29.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 16. Barbu A Welsh N, Saldeen J. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2. Mol Cell Endocrinol 2002;190:75–82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 17. Liu Y Rabinovitch A, Suarez-Pinzon W et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic betacells from apoptosis. Hum Gene Ther 1996;7:1719–26.[Web of Science][Medline]
[Order article via Infotrieve]
- 18. Hamaguchi K Gaskins HR, Leiter HE. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991;40:842–9.[Abstract]
- 19. Augstein P Heinke P, Salzsieder E et al. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice. Endocrinology 2004;145:2747–52.[Abstract/Free Full Text]
- 20. Zumsteg U Frigerio S, Hollander AG. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage. Diabetes 2000;49:39–47.[Abstract]
- 21. Chen M Yang Z, Wu R, Nadler LJ. Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 2002;143:2341–8.[Abstract/Free Full Text]
- 22. Riachy R Vandewalle B, Kerr CJ et al. 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 2002;143:4809–19.[Abstract/Free Full Text]
- 23. Barbu AR Akusjarvi G, Welsh N. Adenoviral-induced islet cell cytotoxicity is not counteracted by Bcl-2 overexpression. Mol Med 2002;8:733–41.[Web of Science][Medline]
[Order article via Infotrieve]
- 24. Contreras JL Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff ED. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002;74:1252–9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 25. Kullin M Li Z, Hansen JB, Bjork E, Sandler S, Karlsson FA. K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes 2000;49:1131–6.[Abstract]
- 26. Augstein P Bahr J, Wachlin G et al. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas. J Autoimmun 2004;23:301–09.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 27. Koshkin V Bikopoulos G, Chan CB, Wheeler MB. The characterization of mitochondrial permeability transition in clonal pancreatic beta-cells. Multiple modes and regulation. J Biol Chem 2004;279:41368–76.[Abstract/Free Full Text]
- 28. Welsh N Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167–73.[Abstract/Free Full Text]
- 29. Kutlu B Cardozo AK, Darville MI et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 2003;52:2701–19.[Abstract/Free Full Text]
- 30. Sakurai K Katoh M, Someno K, Fujimoto Y. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan. Biol Pharm Bull 2001;24:876–82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 31. Scarim AL Nishimoto SY, Weber SM, Corbett AJ. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage. Endocrinology 2003;144:3415–22.[Abstract/Free Full Text]
- 32. Liu D Pavlovic D, Chen MC, Flodstrom M, Sandler S, Eizirik DL. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes 2000;49:1116–22.[Abstract]
- 33. Lüthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 2007;14:641–50.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 34. Siegmund D Klose S, Zhou D et al. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumor cells. Cell Signal 2007;19:1172–84.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 35. Grivennikov SI Kuprah DV, Liu ZG, Nedospasov AS. Intercellular signals and events activated by cytokines of the tumor necrosis factor superfamiliy: from simple paradigms to complex mechanisms. Int Rev Cytol 2006;252:129–61.[Web of Science][Medline]
[Order article via Infotrieve]
- 36. Cottet S Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B. cFLIP Protein prevents tumor necrosis factor-{alpha}-mediated induction of caspase-8-dependent apoptosis in insulin-secreting {beta}Tc-Tet cells. Diabetes 2002;51:1805–14.[Abstract/Free Full Text]
- 37. Siegmund D Wicovsky A, Schmitz I et al. Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing. Mol Cell Biol 2005;25:6363–79.[Abstract/Free Full Text]
- 38. Fumarola C Guidotti GG. Stress-induced apoptosis: toward a symmetry with receptor-mediated cell death. Apoptosis 2004;9:77–82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 39. Hui H Dotta F, Di Mario U, Perfetti R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol 2004;200:177–200.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 40. Martinon F Tschopp J Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007;14:10–22[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 41. Schott WH Haskell BD, Tse HM et al. Caspase-1 is not required for type 1 diabetes in the NOD mouse. Diabetes 2004;53:99–104.[Abstract/Free Full Text]
- 42. Ingelsson E Saldeen J, Welsh N. Islet expression of perforin, Fas/Apo-1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice. Immunol Lett 1998;63:125–9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 43. Karlsen AE Pavlovic D, Nielsen K et al. Interferon-gamma induces interleukin-1 converting enzyme expression in pancreatic islets by an interferon regulatory factor-1-dependent mechanism. J Clin Endocrinol Metab 2000;85:830–6.[Abstract/Free Full Text]
- 44. Lamkanfi M Kalai M, Saelens X, Declercq W, Vandenabeele P. Caspase-1 activates nuclear factor of the {kappa}-enhancer in B cells independently of its enzymatic activity. J Biol Chem 2004;279:24785–93.[Abstract/Free Full Text]
- 45. Kohler M Zaitsev SV, Zaitseva II et al. On-line monitoring of apoptosis in insulin-secreting cells. Diabetes 2003;52:2943–50.[Medline]
[Order article via Infotrieve]
- 46. Huo J Luo RH, Metz SA, Li G. Activation of caspase-2 mediates the apoptosis induced by GTP-depletion in insulin-secreting (HIT-T15) cells 120. Endocrinology 2002;143:1695–704.[Abstract/Free Full Text]
- 47. Green DR Kroemer G Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest 2005;115:2610–17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Diabetes and Vascular Disease Research, Vol. 5, No. 3,
198-204 (2008)
DOI: 10.3132/dvdr.2008.032

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|